<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Pediatric Bipolar on Behaviorism and Mental Health</title>
    <link>https://behaviorismandmentalhealth.com/categories/pediatric-bipolar/</link>
    <description>Recent content in Pediatric Bipolar on Behaviorism and Mental Health</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 04 Dec 2013 05:58:42 +0000</lastBuildDate>
    <atom:link href="https://behaviorismandmentalhealth.com/categories/pediatric-bipolar/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Neuroleptics for Children: Harvard&#39;s Shame</title>
      <link>https://behaviorismandmentalhealth.com/posts/neuroleptics-for-children-harvard-s-shame/</link>
      <pubDate>Wed, 04 Dec 2013 05:58:42 +0000</pubDate>
      <guid>https://behaviorismandmentalhealth.com/posts/neuroleptics-for-children-harvard-s-shame/</guid>
      <description>&lt;p&gt;In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry.  The title is &lt;i&gt;&lt;a href=&#34;http://www.ncbi.nlm.nih.gov/pubmed/22868273&#34;&gt;National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics&lt;/a&gt;.  &lt;/i&gt;The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing for children, adolescents, and adults in outpatient visits.  Here are the results:&lt;/p&gt;
&lt;style&gt;&lt;!--
table { 	border: 1px solid gray;     	border-collapse: collapse;      	width: 500px;   	cellspacing: 0; } th {     	background-color: #eee;          border: 1px solid black; }  th#blank {     	background- color: #FFF;  }  th.colOne {         width: 100px; } td {     	text-align: center;  	border: 1px solid black; } table#diagnosis th.data {         width: 120px; }
--&gt;&lt;/style&gt;
&lt;table id=&#34;antipsychoticRX&#34; cellspacing=&#34;3&#34;&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;th class=&#34;colOne&#34;&gt;Age&lt;/th&gt;
&lt;th&gt;Increase in no. of antipsychotic prescriptions per 100 population (1993-2009)&lt;/th&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;th&gt;0-13&lt;/th&gt;
&lt;td&gt;0.24-1.83 (almost 8-fold)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;th&gt;14-20&lt;/th&gt;
&lt;td&gt;0.78-3.76 (almost 5-fold)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;th&gt;21+&lt;/th&gt;
&lt;td&gt;3.25-6.18 (almost 2-fold)&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&amp;nbsp;
&lt;p&gt;The authors provide a breakdown of the diagnoses assigned to the children and adolescents during the antipsychotic visits.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
